reference/2978336

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2978336

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2541
issn	1528-0020 0006-4971
issueIdentifier	7
pageRange	2534-2541
publicationName	Blood
startingPage	2534
bibliographicCitation	Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, Wiseman G, Gray LA, Schroeder G, Reeder T, Zeldis JB, Tefferi A. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood. 2003 Apr 01;101(7):2534–41. doi: 10.1182/blood-2002-09-2928. PMID: 12517815.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d8c5e4ab1c8d2351f5b245ac140e7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95d73f94f79c8f976d53034e4a92d30b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2993696204a40d173b3458b3e62eeb35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_facf12d94a288764467470c786fb994c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c25a1f8607766ef7329bff8b06c9b995 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dda9d6ee79bdd09c0b06a6ab938ffa39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5c718fa336165be1bad2150c1f8fc8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_691dfcb2dbf8638fed7dde82c52b6eee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f21db4001ebfde1ccbf95b689ef5205 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07d3df2c5dac02d5e18a2d8805b1f0f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab9c7ec89950dfbbbef7b3629b05ebdb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f491b9541cb885ccbecfc4d8b7ce9209
date	2003-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1182/blood-2002-09-2928 https://pubmed.ncbi.nlm.nih.gov/12517815
isPartOf	https://portal.issn.org/resource/ISSN/1528-0020 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1243 https://portal.issn.org/resource/ISSN/0006-4971
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
discusses	http://id.nlm.nih.gov/mesh/M0000480 http://id.nlm.nih.gov/mesh/M0028300 http://id.nlm.nih.gov/mesh/M0021107 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0328153
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055728Q000150 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D055728Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D010198Q000188 http://id.nlm.nih.gov/mesh/D013163Q000209 http://id.nlm.nih.gov/mesh/D018931Q000633 http://id.nlm.nih.gov/mesh/D006411Q000187 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013671 http://id.nlm.nih.gov/mesh/D013792Q000633 http://id.nlm.nih.gov/mesh/D000740Q000209 http://id.nlm.nih.gov/mesh/D011241Q000633 http://id.nlm.nih.gov/mesh/D000740Q000188 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D020533Q000633 http://id.nlm.nih.gov/mesh/D000305Q000008 http://id.nlm.nih.gov/mesh/D010198Q000209 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D000305Q000633 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D020533Q000008 http://id.nlm.nih.gov/mesh/D013163Q000188 http://id.nlm.nih.gov/mesh/D018931Q000008 http://id.nlm.nih.gov/mesh/D000971Q000633
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9285 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11133 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7739 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 75.